JAMES ANDREWS: Open Payments
NPI 1982690129 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 50 payments from 17 companies in 2025. Trend: 2023 $2,184 · 2024 $1,472 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $222 |
| ABBVIE INC. | 9 | $146 |
| PFIZER INC. | 9 | $137 |
| Novo Nordisk Inc | 4 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Astellas Pharma US Inc | 2 | $39 |
| Amgen Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| CORDIS US CORP. | 1 | $33 |
| Radius Health, Inc. | 1 | $27 |
Products named: MOUNJARO, ELIQUIS, UBRELVY, JARDIANCE, VRAYLAR, Ozempic, PREVNAR 20, XIFAXAN.
Industry payments across NC — which companies pay providers there.
